CYP1A1 and atrial fibrillation: Further, it has been shown that AF-resistant and ERα negative cell lines MDA-MB-231 and Hs578T may be re-sensitized to AF through co-treatment with vorinostat, which reactivates ERα expression and AhR-mediated CYP1A1 activity [9].